BetterLife Pharma Inc.
BetterLife Pharma Inc. (BETRF): 1 pipeline candidate · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
0.5 months
D/E 1.83 · 0% dilution
N/A
1 candidate
N/A
N/A
A transparent, data-derived signal for BetterLife Pharma Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7.6M
Cash
$45K
Quarterly Burn
$568K
Runway
0.5 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
Institutional Holdings
Source: SEC Form 13F · as of Dec 2023Institutional holders
2
Total value held
$192
| Holder | Shares | Value |
|---|---|---|
| bartlett & co. wealth management llc | 4,000 | $192 |
| bartlett & co. llc | 4,000 | $0 |
Frequently asked questions
How many drug candidates are in BetterLife Pharma Inc.'s pipeline?
BetterLife Pharma Inc. (BETRF) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is BetterLife Pharma Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, BetterLife Pharma Inc. has approximately 0.5 months of cash runway.
What is BetterLife Pharma Inc.'s market capitalization?
BetterLife Pharma Inc.'s market capitalization is approximately $7.6M.
Who is the CEO of BetterLife Pharma Inc.?
Dr. Ahmad Doroudian Ph.D. is the chief executive officer of BetterLife Pharma Inc. (BETRF).
Get the full picture on BetterLife Pharma Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.